Gene · 5037
Papers2,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Protein Post-Translational Modifications in the Pathogenesis of Nephrolithiasis: Mechanistic Insights and Translational Potential. | Cells | 2026 | 41892343 | PubTator, text mining | PubMed |
| The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells. | Front Oncol | 2026 | 41847707 | PubTator, text mining | PubMed |
| A control theoretical approach to gene regulation reveals quantitative constraints for dynamic homeostasis in stochastic gene expression. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41830847 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| A bridge between embryonic development and disease: The converging regulatory roles of RKIP and YY1. | Biochim Biophys Acta Rev Cancer | 2026 | 41765209 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis identifies ferroptosis-related biomarkers and subtypes in invasive aspergillosis. | Toxicol Res (Camb) | 2026 | 41756099 | PubTator, text mining | PubMed |
| RAPseq enables large-scale identification of RBP-RNA interactions and reveals essentials of post-transcriptional gene regulation. | Nucleic Acids Res | 2026 | 41755635 | PubTator, text mining | PubMed |
| Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | 41754792 | PubTator, text mining | PubMed |
| Systematic Examination of Gene Expression and Proteomic Evidence Across Tissues Supports the Role of Mitochondrial Dysregulation in ME/CFS. | Int J Mol Sci | 2026 | 41752134 | PubTator, text mining | PubMed |
| Target Fidelity and Failure: Structure-Activity Relationship of High-Molecular-Mass Penicillin-Binding Proteins (HMM-PBPs) in Refractory Granulicatella adiacens Endocarditis. | Antibiotics (Basel) | 2026 | 41750466 | PubTator, text mining | PubMed |
| Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand. | Antibiotics (Basel) | 2026 | 41750431 | PubTator, text mining | PubMed |
| The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion. | Cells | 2026 | 41744762 | PubTator, text mining | PubMed |
| Evaluating Semaglutide's Protection in H/R - Injured AC16 Cardiomyocytes: Oxidative Stress, Inflammation, Apoptosis, and Autophagy Insights. | Int J Gen Med | 2026 | 41737537 | PubTator, text mining | PubMed |
| Unveiling melatonin's multifaceted actions against ferroptotic neurotoxicity in ischemic stroke. | Toxicol Rep | 2026 | 41732549 | PubTator, text mining | PubMed |
| Identification and validation of paraptosis-related prognostic biomarkers in lung adenocarcinoma: An observational study based on transcriptomics and clinical outcomes. | Medicine (Baltimore) | 2026 | 41731832 | PubTator, text mining | PubMed |
| Synthesis, in vitro antimicrobial activity and docking studies of novel 1,2,4-oxadiazole based piperidin-1-yl-methanone analogues. | Bioorg Med Chem Lett | 2026 | 41720410 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| Anti-cancer effect of palmitic acid against the endometrial cancer progression via inducing ferroptosis. | Biochem Biophys Rep | 2026 | 41717082 | PubTator, text mining | PubMed |
| Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects. | Front Endocrinol (Lausanne) | 2026 | 41710412 | PubTator, text mining | PubMed |
| Gasotransmitters bridging tumor biology and immunity: from pathophysiological insights to therapeutic potential. | Front Immunol | 2026 | 41694345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5037/papers?page=2